Akso Health Group
AHG
4 hedge funds and large institutions have $829K invested in Akso Health Group in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
44% more capital invested
Capital invested by funds: $575K → $829K (+$254K)
33% more funds holding
Funds holding: 3 → 4 (+1)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$40K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$67 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$16.6K |
AHG Hedge Fund Activity: Q3 2021 in Review
4 of the 5,729 institutional investors tracked by Wall St. Rank reported a position in Akso Health Group (AHG) for Q3 2021, worth a combined $829K — up 44% from $575K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new AHG positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $40K. The largest seller was Citadel Advisors, cutting an estimated $16.6K.
- 4 institutional investors held Akso Health Group (AHG) as of Q3 2021, up from 3 in Q2 2021.
- Funds reported $829K of Akso Health Group stock for Q3 2021, up 44% quarter-over-quarter.
- 1 fund opened new Akso Health Group positions in Q3 2021 and 0 closed out, a net change of +1 holder.
- The largest Akso Health Group buyer in Q3 2021 was Renaissance Technologies, an estimated $40K added.
- The largest Akso Health Group seller in Q3 2021 was Citadel Advisors, an estimated $16.6K sold.
Based on aggregated 13F filings for Q3 2021.